CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Current Assets
Cash and cash equivalents	$ 180,116,752	$ 144,937,893
Time deposits	0	38,032,593
Accounts receivable, net of allowance for doubtful accounts	30,593,102	25,144,969
Inventories	130,877,257	126,395,312
Prepayments and other current assets, net of allowance for doubtful accounts	21,663,389	24,545,597
Deposits related to land use rights, current portion	10,307,682	10,056,200
Total Current Assets	373,558,182	369,112,564
Property, plant and equipment, net	115,500,723	105,364,251
Land use rights, net	24,932,269	23,576,300
Equity method investment	8,543,149	8,718,133
Loan receivable	46,431,000	39,834,173
Other non-current assets	3,199,391	4,861,075
Total Assets	572,164,714	551,466,496
Current Liabilities
Accounts payable	5,994,820	9,681,835
Other payables and accrued expenses	42,626,588	57,462,563
Income tax payable	8,226,534	4,510,986
Total Current Liabilities	56,847,942	71,655,384
Deferred income	4,420,053	4,525,867
Other liabilities	6,703,382	8,323,446
Total Liabilities	67,971,377	84,504,697
Stockholders' Equity
Common stock: par value $0.0001; 100,000,000 shares authorized; 28,845,678 and 28,835,053 shares issued at March 31, 2016 and December 31, 2015, respectively; 26,590,974 and 26,580,349 shares outstanding at March 31, 2016 and December 31, 2015, respectively	2,885	2,884
Additional paid-in capital	109,649,239	105,079,845
Treasury stock: 2,254,704 shares at March 31, 2016 and December 31, 2015, at cost	(56,425,094)	(56,425,094)
Retained earnings	359,901,349	333,704,094
Accumulated other comprehensive income	2,108,251	(18,605)
Total equity attributable to China Biologic Products, Inc.	415,236,630	382,343,124
Noncontrolling interest	88,956,707	84,618,675
Total Stockholders’ Equity	$ 504,193,337	$ 466,961,799
Commitments and contingencies
Total Liabilities and Stockholders’ Equity	$ 572,164,714	$ 551,466,496